Trial Site Detail

 

Drug:
Regorafenib (SDH)
Trial:
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST (REGISTRI)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Centre Léon Bérard

28 rue Laennec     
Lyon , Rhone 69373
France

 

Principal Investigator:
Jean Yves-Blay, MD, PhD
Contact:
Julien Gautier julien.gautier@lyon.unicancer.fr
Activation Status of this Site:
Active
Notes about this Site:
Centre Léon Bérard Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.